Literature DB >> 18188442

Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative.

Ronald C Kessler1, Matthias Angermeyer, James C Anthony, Ron DE Graaf, Koen Demyttenaere, Isabelle Gasquet, Giovanni DE Girolamo, Semyon Gluzman, Oye Gureje, Josep Maria Haro, Norito Kawakami, Aimee Karam, Daphna Levinson, Maria Elena Medina Mora, Mark A Oakley Browne, José Posada-Villa, Dan J Stein, Cheuk Him Adley Tsang, Sergio Aguilar-Gaxiola, Jordi Alonso, Sing Lee, Steven Heeringa, Beth-Ellen Pennell, Patricia Berglund, Michael J Gruber, Maria Petukhova, Somnath Chatterji, T Bedirhan Ustün.   

Abstract

Data are presented on the lifetime prevalence, projected lifetime risk, and age-of-onset distributions of mental disorders in the World Health Organization (WHO)'s World Mental Health (WMH) Surveys. Face-to-face community surveys were conducted in seventeen countries in Africa, Asia, the Americas, Europe, and the Middle East. The combined numbers of respondents were 85,052. Lifetime prevalence, projected lifetime risk, and age of onset of DSM-IV disorders were assessed with the WHO Composite International Diagnostic Interview (CIDI), a fully-structured lay administered diagnostic interview. Survival analysis was used to estimate lifetime risk. Median and inter-quartile range (IQR) of age of onset is very early for some anxiety disorders (7-14, IQR: 8-11) and impulse control disorders (7-15, IQR: 11-12). The age-of-onset distribution is later for mood disorders (29-43, IQR: 35-40), other anxiety disorders (24-50, IQR: 31-41), and substance use disorders (18-29, IQR: 21-26). Median and IQR lifetime prevalence estimates are: anxiety disorders 4.8-31.0% (IQR: 9.9-16.7%), mood disorders 3.3-21.4% (IQR: 9.8-15.8%), impulse control disorders 0.3-25.0% (IQR: 3.1-5.7%), substance use disorders 1.3-15.0% (IQR: 4.8-9.6%), and any disorder 12.0-47.4% (IQR: 18.1-36.1%). Projected lifetime risk is proportionally between 17% and 69% higher than estimated lifetime prevalence (IQR: 28-44%), with the highest ratios in countries exposed to sectarian violence (Israel, Nigeria, and South Africa), and a general tendency for projected risk to be highest in recent cohorts in all countries. These results document clearly that mental disorders are commonly occurring. As many mental disorders begin in childhood or adolescents, interventions aimed at early detection and treatment might help reduce the persistence or severity of primary disorders and prevent the subsequent onset of secondary disorders.

Entities:  

Keywords:  Mental disorders; age-of-onset distribution; lifetime prevalence; projected lifetime risk

Year:  2007        PMID: 18188442      PMCID: PMC2174588     

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


  31 in total

1.  Cross-national epidemiology of major depression and bipolar disorder.

Authors:  M M Weissman; R C Bland; G J Canino; C Faravelli; S Greenwald; H G Hwu; P R Joyce; E G Karam; C K Lee; J Lellouch; J P Lépine; S C Newman; M Rubio-Stipec; J E Wells; P J Wickramaratne; H Wittchen; E K Yeh
Journal:  JAMA       Date:  1996 Jul 24-31       Impact factor: 56.272

2.  Early developmental stages of psychopathology study (EDSP): objectives and design.

Authors:  H U Wittchen; A Perkonigg; G Lachner; C B Nelson
Journal:  Eur Addict Res       Date:  1998-03       Impact factor: 3.015

3.  National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity.

Authors:  L N Robins; J E Helzer; J Croughan; K S Ratcliff
Journal:  Arch Gen Psychiatry       Date:  1981-04

4.  Twelve-month prevalence, severity, and unmet need for treatment of mental disorders in metropolitan China.

Authors:  Yu-Cun Shen; Ming-Yuan Zhang; Yue-Qin Huang; Yan-Ling He; Zhao-Rui Liu; Hui Cheng; Adley Tsang; Sing Lee; Ronald C Kessler
Journal:  Psychol Med       Date:  2005-12-07       Impact factor: 7.723

5.  Lifetime prevalence of DSM-III-R psychiatric disorders among urban and rural Mexican Americans in California.

Authors:  W A Vega; B Kolody; S Aguilar-Gaxiola; E Alderete; R Catalano; J Caraveo-Anduaga
Journal:  Arch Gen Psychiatry       Date:  1998-09

6.  Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology.

Authors: 
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

7.  Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys.

Authors:  Josep Maria Haro; Saena Arbabzadeh-Bouchez; Traolach S Brugha; Giovanni de Girolamo; Margaret E Guyer; Robert Jin; Jean Pierre Lepine; Fausto Mazzi; Blanca Reneses; Gemma Vilagut; Nancy A Sampson; Ronald C Kessler
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

8.  Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys.

Authors:  Koen Demyttenaere; Ronny Bruffaerts; Jose Posada-Villa; Isabelle Gasquet; Viviane Kovess; Jean Pierre Lepine; Matthias C Angermeyer; Sebastian Bernert; Giovanni de Girolamo; Pierluigi Morosini; Gabriella Polidori; Takehiko Kikkawa; Norito Kawakami; Yutaka Ono; Tadashi Takeshima; Hidenori Uda; Elie G Karam; John A Fayyad; Aimee N Karam; Zeina N Mneimneh; Maria Elena Medina-Mora; Guilherme Borges; Carmen Lara; Ron de Graaf; Johan Ormel; Oye Gureje; Yucun Shen; Yueqin Huang; Mingyuan Zhang; Jordi Alonso; Josep Maria Haro; Gemma Vilagut; Evelyn J Bromet; Semyon Gluzman; Charles Webb; Ronald C Kessler; Kathleen R Merikangas; James C Anthony; Michael R Von Korff; Philip S Wang; Traolach S Brugha; Sergio Aguilar-Gaxiola; Sing Lee; Steven Heeringa; Beth-Ellen Pennell; Alan M Zaslavsky; T Bedirhan Ustun; Somnath Chatterji
Journal:  JAMA       Date:  2004-06-02       Impact factor: 56.272

9.  Sampling and methods of the European Study of the Epidemiology of Mental Disorders (ESEMeD) project.

Authors:  J Alonso; M C Angermeyer; S Bernert; R Bruffaerts; T S Brugha; H Bryson; G de Girolamo; R Graaf; K Demyttenaere; I Gasquet; J M Haro; S J Katz; R C Kessler; V Kovess; J P Lépine; J Ormel; G Polidori; L J Russo; G Vilagut; J Almansa; S Arbabzadeh-Bouchez; J Autonell; M Bernal; M A Buist-Bouwman; M Codony; A Domingo-Salvany; M Ferrer; S S Joo; M Martínez-Alonso; H Matschinger; F Mazzi; Z Morgan; P Morosini; C Palacín; B Romera; N Taub; W A M Vollebergh
Journal:  Acta Psychiatr Scand Suppl       Date:  2004

10.  Epidemiologic evidence for early onset of mental disorders and higher risk of drug abuse in young adults.

Authors:  K A Christie; J D Burke; D A Regier; D S Rae; J H Boyd; B Z Locke
Journal:  Am J Psychiatry       Date:  1988-08       Impact factor: 18.112

View more
  573 in total

1.  Onset, Comorbidity, and Predictors of Nicotine, Alcohol, and Marijuana Use Disorders Among North American Indigenous Adolescents.

Authors:  Dane Hautala; Kelley Sittner; Melissa Walls
Journal:  J Abnorm Child Psychol       Date:  2019-06

Review 2.  Exercise-based treatments for substance use disorders: evidence, theory, and practicality.

Authors:  Sarah E Linke; Michael Ussher
Journal:  Am J Drug Alcohol Abuse       Date:  2014-11-14       Impact factor: 3.829

3.  Heritability of volumetric brain changes and height in children entering puberty.

Authors:  Inge L C van Soelen; Rachel M Brouwer; G Caroline M van Baal; Hugo G Schnack; Jiska S Peper; Lei Chen; René S Kahn; Dorret I Boomsma; Hilleke E Hulshoff Pol
Journal:  Hum Brain Mapp       Date:  2011-12-03       Impact factor: 5.038

4.  Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans.

Authors:  Jennifer L Warner-Schmidt; Kimberly E Vanover; Emily Y Chen; John J Marshall; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

5.  Pain in the Developing Brain: Early Life Factors Alter Nociception and Neurobiological Function in Adolescent Rats.

Authors:  Sabrina Salberg; Glenn R Yamakawa; Yannick Griep; Jesse Bain; Jaimie K Beveridge; Mujun Sun; Stuart J McDonald; Sandy R Shultz; Rhys D Brady; David K Wright; Melanie Noel; Richelle Mychasiuk
Journal:  Cereb Cortex Commun       Date:  2021-02-24

6.  Exploring Comorbidity Within Mental Disorders Among a Danish National Population.

Authors:  Oleguer Plana-Ripoll; Carsten Bøcker Pedersen; Yan Holtz; Michael E Benros; Søren Dalsgaard; Peter de Jonge; Chun Chieh Fan; Louisa Degenhardt; Andrea Ganna; Aja Neergaard Greve; Jane Gunn; Kim Moesgaard Iburg; Lars Vedel Kessing; Brian K Lee; Carmen C W Lim; Ole Mors; Merete Nordentoft; Anders Prior; Annelieke M Roest; Sukanta Saha; Andrew Schork; James G Scott; Kate M Scott; Terry Stedman; Holger J Sørensen; Thomas Werge; Harvey A Whiteford; Thomas Munk Laursen; Esben Agerbo; Ronald C Kessler; Preben Bo Mortensen; John J McGrath
Journal:  JAMA Psychiatry       Date:  2019-03-01       Impact factor: 21.596

7.  A meta-analysis of the effect of therapist experience on outcomes for clients with internalizing disorders.

Authors:  Lucia M Walsh; McKenzie K Roddy; Kelli Scott; Cara C Lewis; Amanda Jensen-Doss
Journal:  Psychother Res       Date:  2018-05-03

8.  Profiles of childhood trauma and psychopathology: US National Epidemiologic Survey.

Authors:  Emma Curran; Gary Adamson; Michael Rosato; Paul De Cock; Gerard Leavey
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-05-03       Impact factor: 4.328

Review 9.  Developmental rodent models of fear and anxiety: from neurobiology to pharmacology.

Authors:  Despina E Ganella; Jee Hyun Kim
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

10.  Associations between DSM-IV mental disorders and subsequent self-reported diagnosis of cancer.

Authors:  Siobhan O'Neill; Jose Posada-Villa; Maria Elena Medina-Mora; Ali Obaid Al-Hamzawi; Marina Piazza; Hisateru Tachimori; Chiyi Hu; Carmen Lim; Ronny Bruffaerts; Jean-Pierre Lépine; Herbert Matschinger; Giovanni de Girolamo; Peter de Jonge; Jordi Alonso; Jose Miguel Caldas-de-Almeida; Silvia Florescu; Andrzej Kiejna; Daphna Levinson; Ronald C Kessler; Kate M Scott
Journal:  J Psychosom Res       Date:  2014-01-09       Impact factor: 3.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.